Jan-22-2019   15:19 Hrs IST
Karda Constructions rises on planning to raise funds via NCDs
+

Karda Constructions is currently trading at Rs. 204.00, up by 1.40 points or 0.69% from its previous closing of Rs. 202.60 on the BSE.

The scrip opened at Rs. 202.25 and has touched a high and low of Rs. 204.55 and Rs. 201.15 respectively. So far 496 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 236.85 on 18-Sep-2018 and a 52 week low of Rs. 124.35 on 26-Oct-2018.

Last one week high and low of the scrip stood at Rs. 212.50 and Rs. 201.05 respectively. The current market cap of the company is Rs. 251.60 crore.

The promoters holding in the company stood at 65.04%, while Institutions and Non-Institutions held 1.12% and 33.83% respectively.

Karda Constructions is planning to raise funds by way of issue of Debt Security in the form of Non-convertible Debenture (NCDs) on private placement basis. The meeting of the Board of Directors of the Company is scheduled to be held on January 24, 2019, to consider the same.

Karda Constructions is primarily in construction of residential projects and recently they have been innovative in their approach to push the affordable housing segment by coming up with schemes such as ‘Capsule Homes’.

Jan-22-2019   14:59 Hrs IST
Alembic Pharma gains on getting USFDA’s nod for Desvenlafaxine Extended-Release Tablets
+

Alembic Pharmaceuticals is currently trading at Rs. 599.00, up by 7.65 points or 1.29% from its previous closing of Rs. 591.35 on the BSE.

The scrip opened at Rs. 588.35 and has touched a high and low of Rs. 612.50 and Rs. 588.35 respectively. So far 24248 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 664.00 on 27-Sep-2018 and a 52 week low of Rs. 412.40 on 24-May-2018.

Last one week high and low of the scrip stood at Rs. 612.75 and Rs. 582.20 respectively. The current market cap of the company is Rs. 11442.92 crore.

The promoters holding in the company stood at 72.96%, while Institutions and Non-Institutions held 15.05% and 11.99% respectively.

Alembic Pharmaceuticals has received approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Desvenlafaxine Extended-Release Tablets, 25 mg. The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), PRISTIQ Extended-Release Tablets, 25 mg of Wyeth Pharma. Desvenlafaxine Extended-Release Tablets, 25 mg are indicated for the treatment of major depressive disorder (MDD).

Desvenlafaxine Extended-Release Tablets, 25 mg has an estimated market size of $ 13.3 million for twelve months ending December 2017 according to IQVIA

Alembic now has a total of 77 ANDA approvals (64 final approvals and 13 tentative approvals) from USFDA.

Alembic Pharmaceuticals, a vertically integrated research and development pharmaceutical company, has been at the forefront of Healthcare since 1907.


Jan-22-2019   14:49 Hrs IST
Havells India shines on reporting marginal rise in Q3 net profit
+

Havells India is currently trading at Rs. 709.55, up by 31.70 points or 4.68% from its previous closing of Rs. 677.85 on the BSE.

The scrip opened at Rs. 677.10 and has touched a high and low of Rs. 720.30 and Rs. 670.60 respectively. So far 263751 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 728.95 on 03-Sep-2018 and a 52 week low of Rs. 454.00 on 06-Feb-2018.

Last one week high and low of the scrip stood at Rs. 693.00 and Rs. 671.45 respectively. The current market cap of the company is Rs. 43861.29 crore.

The promoters holding in the company stood at 59.55%, while Institutions and Non-Institutions held 31.43% and 9.01% respectively.

Havells India has reported a marginal rise of 0.67% in its net profit at Rs 195.67 crore for the quarter ended December 31, 2018 as compared to Rs 194.36 crore for the same quarter in the previous year. Total income of the company increased by 27.99% at Rs 2551.49 crore for Q3FY19 as compared Rs 1993.53 crore for the corresponding quarter previous year.

Havells India is a leading FMEG company (Fast moving electrical goods) with presence across India. Its product range includes Industrial & Domestic Circuit Protection Switchgear, Cables&  Wires,  Motors,  Fans,  Power  Capacitors,  Luminaires  for  Domestic,  Commercial  & Industrial applications, Modular Switches etc.

Jan-22-2019   14:31 Hrs IST
TVS Motor shines on reporting 16% rise in Q3 net profit
+

TVS Motor Company is currently trading at Rs. 555.00, up by 16.95 points or 3.15% from its previous closing of Rs. 538.05 on the BSE.

The scrip opened at Rs. 535.00 and has touched a high and low of Rs. 559.90 and Rs. 520.60 respectively. So far 545200 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 734.00 on 30-Jan-2018 and a 52 week low of Rs. 478.70 on 08-Oct-2018.

Last one week high and low of the scrip stood at Rs. 559.90 and Rs. 520.60 respectively. The current market cap of the company is Rs. 26331.70 crore.

The promoters holding in the company stood at 57.40%, while Institutions and Non-Institutions held 30.96% and 11.64% respectively.

TVS Motor Company has reported 15.57% rise in its net profit at Rs 178.39 crore for the quarter ended December 31, 2018 as compared to Rs 154.35 crore for the same quarter in the previous year. Total income of the company increased by 25.97% at Rs 4664.63 crore for Q3FY19 as compared Rs 3703.11 crore for the corresponding quarter previous year.

TVS Motor Company is a leading two and three-wheeler manufacturer, and is the flagship company of the TVS Group.

Jan-22-2019   14:16 Hrs IST
Lupin slips on the bourses
+

Lupin is currently trading at Rs. 863.00, down by 2.50 points or 0.29% from its previous closing of Rs. 865.50 on the BSE.

The scrip opened at Rs. 865.05 and has touched a high and low of Rs. 872.00 and Rs. 851.50 respectively. So far 34675 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 986.00 on 10-Sep-2018 and a 52 week low of Rs. 723.55 on 15-May-2018.

Last one week high and low of the scrip stood at Rs. 879.10 and Rs. 845.50 respectively. The current market cap of the company is Rs. 38958.89 crore.

The promoters holding in the company stood at 46.98%, while Institutions and Non-Institutions held 38.84% and 14.18% respectively.

Lupin is voluntarily recalling 55,000 vials and 1,60,241 boxes of anti-bacterial drug Ceftriaxone for injection in various strengths. The recall has been initiated by Lupin Pharmaceuticals, Inc, a subsidiary of the company. The products have been manufactured at the company's facility in Mandideep in the state of Madhya Pradesh.

The company is recalling specific lots of drugs due to the presence of shredded rubber particulate matter from the stopper observed in reconstituted vials. The ongoing voluntary nationwide recall has been classified as Class-I. Such recalls are for dangerous or defective products that predictably could cause serious health problems.

Lupin Pharmaceuticals is also recalling 2,87,784 bottles of Cefdinir for Oral Suspension, used to treat bacterial infections for CGMP (Current Good Manufacturing Practice) deviations. It is classified as a Class-II recall, which is initiated in a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.

Lupin is an innovation led transnational pharmaceutical company developing and delivering a wide range of branded & generic formulations, biotechnology products and APIs globally.

Jan-22-2019   13:00 Hrs IST
SpiceJet flies high on reporting passenger load factor of 92.7% in December
+

Spicejet is currently trading at Rs. 80.55, up by 0.25 points or 0.31% from its previous closing of Rs. 80.30 on the BSE.

The scrip opened at Rs. 80.10 and has touched a high and low of Rs. 80.85 and Rs. 79.45 respectively. So far 225590 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 154.00 on 14-Feb-2018 and a 52 week low of Rs. 60.60 on 04-Oct-2018.

Last one week high and low of the scrip stood at Rs. 85.95 and Rs. 79.45 respectively. The current market cap of the company is Rs. 4813.58 crore.

The promoters holding in the company stood at 60.03%, while Institutions and Non-Institutions held 10.05% and 29.92% respectively.

SpiceJet has reported the Passenger Load Factor (PLF) of 92.7% during the month of December 2018. The company had reported PLF of 91.1% during the month of November 2018.

The PLF is a key indicator of the company’s performance, as it measures the average percentage of seats filled on airline’s aircraft fleet.

SpiceJet is among the first private companies that stepped into the Indian aviation sector.

Jan-22-2019   12:48 Hrs IST
Torrent Pharmaceuticals gains on the bourses
+

Torrent Pharmaceuticals is currently trading at Rs. 1912.15, up by 33.90 points or 1.80% from its previous closing of Rs. 1878.25 on the BSE.

The scrip opened at Rs. 1846.00 and has touched a high and low of Rs. 1913.45 and Rs. 1846.00 respectively. So far 3667 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 1960.00 on 16-Jan-2019 and a 52 week low of Rs. 1223.75 on 22-Mar-2018.

Last one week high and low of the scrip stood at Rs. 1960.00 and Rs. 1846.00 respectively. The current market cap of the company is Rs. 32169.24 crore.

The promoters holding in the company stood at 71.25%, while Institutions and Non-Institutions held 19.01% and 9.74% respectively.

Torrent group will invest Rs 10,000 crore in renewable energy, power and gas distribution businesses in Gujarat. The group has already invested Rs 30,000 crore in the state in power and pharmaceutical sectors.

Torrent Pharmaceuticals is Flagship Company of the Torrent group, a leader in cardiovascular and central nervous system segments. It also has presence in gastro-intestinal, diabetology, anti-infective and pain management segments.

Jan-22-2019   12:34 Hrs IST
InterGlobe Aviation surges on reporting passenger load factor of 88.9% in December
+

Interglobe Aviation is currently trading at Rs. 1079.95, up by 17.15 points or 1.61% from its previous closing of Rs. 1062.80 on the BSE.

The scrip opened at Rs. 1055.70 and has touched a high and low of Rs. 1084.50 and Rs. 1048.85 respectively. So far 23724 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 1520.00 on 20-Apr-2018 and a 52 week low of Rs. 697.00 on 09-Oct-2018.

Last one week high and low of the scrip stood at Rs. 1145.30 and Rs. 1048.85 respectively. The current market cap of the company is Rs. 41168.05 crore.

The promoters holding in the company stood at 74.93%, while Institutions and Non-Institutions held 20.37% and 4.70% respectively.

Interglobe Aviation (IndiGo) has reported the Passenger Load Factor (PLF) of 88.9% during the month of December 2018. The company had reported PLF of 84.9% during November 2018. The PLF is a key indicator of the company’s performance, as it measures the average percentage of seats filled on airline’s aircraft fleet.

InterGlobe Aviation provides air transportation services in India and internationally. The company primarily operates IndiGo passenger airline.

Jan-22-2019   12:18 Hrs IST
Skipper rises on the bourses
+

Skipper is currently trading at Rs. 78.15, up by 0.80 points or 1.03% from its previous closing of Rs. 77.35 on the BSE.

The scrip opened at Rs. 77.25 and has touched a high and low of Rs. 78.75 and Rs. 77.00 respectively. So far 3060 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 1 has touched a 52 week high of Rs. 279.00 on 22-Jan-2018 and a 52 week low of Rs. 76.70 on 21-Jan-2019.

Last one week high and low of the scrip stood at Rs. 87.00 and Rs. 76.70 respectively. The current market cap of the company is Rs. 805.96 crore.

The promoters holding in the company stood at 71.88%, while Institutions and Non-Institutions held 16.01% and 12.11% respectively.

Skipper has received CE marking certificate from SGS (SGS United Kingdom) in compliance with Regulation of the European Parliament and of the Council of March 9, 2011 (the Construction Products Regulation or CPR) for its products (Towers, Towers Accessories, Fasteners, Angles, Swaged type steel tubular poles, High Masts, Conical Poles, Polygonal Poles with accessories etc).

CE marking certification is a pre-requisition for the manufacturers to enter into Key European markets and this will give a boost to the company's engineering product exports in European region.

Skipper is engaged in structural fabrication and manufacturing of mild steel and galvanized iron pipes, steel tubular poles, scaffolding and accessories and PVC pipes. Structural fabrication is the major contributor to the revenue of the company.

Jan-22-2019   11:57 Hrs IST
Sun Pharma trades higher on the BSE
+

Sun Pharmaceutical Industries is currently trading at Rs. 417.15, up by 18.80 points or 4.72% from its previous closing of Rs. 398.35 on the BSE.

The scrip opened at Rs. 408.60 and has touched a high and low of Rs. 421.15 and Rs. 408.60 respectively. So far 1447242 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 678.80 on 06-Sep-2018 and a 52 week low of Rs. 375.40 on 18-Jan-2019.

Last one week high and low of the scrip stood at Rs. 457.15 and Rs. 375.40 respectively. The current market cap of the company is Rs. 100459.87 crore.

The promoters holding in the company stood at 54.38%, while Institutions and Non-Institutions held 32.53% and 13.09% respectively.

Sun Pharmaceutical Industries is going to replace its domestic formulations distributor Aditya Medisales with its own subsidiary in the backdrop of a second whistleblower complaint filed against the company. This change will be made effective by Q1FY20, post receipt of all requisite regulatory approvals.

Sun Pharmaceutical Industries is the world’s fourth largest specialty generic pharmaceutical company and India’s top pharmaceutical company.

~*44